Dong Mei Su
Directeur/Membre du Conseil chez 3SBIO INC.
Fortune : 20 M $ au 30/04/2024
Postes actifs de Dong Mei Su
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| 3SBIO INC. | Directeur/Membre du Conseil | 11/06/2012 | - |
| Corporate Officer/Principal | 27/11/2014 | - | |
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Directeur/Membre du Conseil | 09/09/2022 | - |
| Liaoning Sunshine Bio-Pharmaceutical Co., Ltd. | Directeur/Membre du Conseil | 01/11/2006 | - |
| Liaoning Sunshine Science & Technology Development Co. Ltd. | Directeur/Membre du Conseil | 01/09/2009 | - |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Directeur/Membre du Conseil | 01/01/1993 | - |
| Corporate Officer/Principal | 01/01/1993 | - | |
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
 Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | Directeur/Membre du Conseil | 16/11/2018 | - |
Strategic International Group Ltd.
 Strategic International Group Ltd. Miscellaneous Commercial ServicesCommercial Services Strategic International Group Ltd. Provides financial services. The company is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Dong Mei Su
Anciens postes connus de Dong Mei Su
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Hongkong Sansheng Medical Ltd.
 Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | Directeur/Membre du Conseil | 01/11/2009 | 01/11/2014 |
Guangdong Sunshine Pharmaceutical Co., Ltd.
 Guangdong Sunshine Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2016, Guangdong Sunshine Pharmaceutical Co., Ltd. is a subsidiary of 3SBio, Inc. that manufactures and markets biopharmaceutical products. The company is based in Dongguan, China. | Directeur/Membre du Conseil | - | - |
Formation de Dong Mei Su
| Jilin University | Undergraduate Degree |
| Shenyang Pharmaceutical University | Graduate Degree |
Statistiques
Internationale
| Chine | 9 |
| Îles Cayman | 2 |
| Hong Kong | 2 |
Opérationnelle
| Director/Board Member | 9 |
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| 3SBIO INC. | Health Technology |
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Health Technology |
| Entreprise privées | 7 |
|---|---|
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | Health Technology |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | Health Technology |
Strategic International Group Ltd.
Strategic International Group Ltd. Miscellaneous Commercial ServicesCommercial Services Strategic International Group Ltd. Provides financial services. The company is headquartered in London, the United Kingdom. | Commercial Services |
Guangdong Sunshine Pharmaceutical Co., Ltd.
Guangdong Sunshine Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2016, Guangdong Sunshine Pharmaceutical Co., Ltd. is a subsidiary of 3SBio, Inc. that manufactures and markets biopharmaceutical products. The company is based in Dongguan, China. | Health Technology |
| Liaoning Sunshine Bio-Pharmaceutical Co., Ltd. | |
| Liaoning Sunshine Science & Technology Development Co. Ltd. |
- Bourse
- Insiders
- Dong Mei Su
- Expérience
